CN102859361B - 癌症预后分析 - Google Patents

癌症预后分析 Download PDF

Info

Publication number
CN102859361B
CN102859361B CN201180008402.0A CN201180008402A CN102859361B CN 102859361 B CN102859361 B CN 102859361B CN 201180008402 A CN201180008402 A CN 201180008402A CN 102859361 B CN102859361 B CN 102859361B
Authority
CN
China
Prior art keywords
cancer
flc
light chain
purposes
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180008402.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN102859361A (zh
Inventor
A·布拉德韦尔
G·米德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Binding Site Group Ltd
Original Assignee
Binding Site Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Binding Site Group Ltd filed Critical Binding Site Group Ltd
Priority claimed from PCT/GB2011/050193 external-priority patent/WO2011095818A1/en
Publication of CN102859361A publication Critical patent/CN102859361A/zh
Application granted granted Critical
Publication of CN102859361B publication Critical patent/CN102859361B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201180008402.0A 2010-02-05 2011-02-04 癌症预后分析 Active CN102859361B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1001950.3A GB201001950D0 (en) 2010-02-05 2010-02-05 Infection prognostic assay
GB1001950.3 2010-02-05
PCT/GB2011/050193 WO2011095818A1 (en) 2010-02-05 2011-02-04 Cancer prognosis assay

Publications (2)

Publication Number Publication Date
CN102859361A CN102859361A (zh) 2013-01-02
CN102859361B true CN102859361B (zh) 2015-06-17

Family

ID=42082582

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201180008402.0A Active CN102859361B (zh) 2010-02-05 2011-02-04 癌症预后分析
CN201180008422.8A Active CN102859362B (zh) 2010-02-05 2011-02-04 感染预后分析

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201180008422.8A Active CN102859362B (zh) 2010-02-05 2011-02-04 感染预后分析

Country Status (6)

Country Link
US (2) US20130217030A1 (https=)
EP (1) EP2531857B1 (https=)
JP (2) JP5818817B2 (https=)
CN (2) CN102859361B (https=)
GB (1) GB201001950D0 (https=)
WO (1) WO2011095820A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2519564A (en) * 2013-10-24 2015-04-29 Shared Band Ltd Multicast transmission over bonded broadband
US20170252364A1 (en) * 2014-07-30 2017-09-07 Mor Research Applications Ltd. Compositions for treatment of acute lymphoblastic leukemia and methods of use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
WO2006079816A1 (en) * 2005-01-27 2006-08-03 The Binding Site Limited Method of detecting or monitoring a malignant plasma cell disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792529A (en) * 1985-10-18 1988-12-20 University Of Rochester Immunoassay of free kappa light chains for the detection of multiple sclerosis
IT1216698B (it) * 1988-04-01 1990-03-08 New Scient Co Spa Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente.
EP0862584B1 (en) 1995-11-03 2004-12-22 The Binding Site Limited Production of antibodies
US6322788B1 (en) * 1998-08-20 2001-11-27 Stanley Arthur Kim Anti-bacterial antibodies and methods of use
JP4438455B2 (ja) * 2004-03-04 2010-03-24 ヤマサ醤油株式会社 遊離ヒトイムノグロブリン軽鎖の測定法及びキット
US20090082304A1 (en) * 2004-11-12 2009-03-26 Northwestern University Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs
US7781178B2 (en) * 2005-04-12 2010-08-24 Akira Matsumori Biomarker for diagnosing heart disease and the use thereof
JP2007292661A (ja) * 2006-04-26 2007-11-08 Akira Matsumori 活動性心筋炎の検出方法および検出試薬
GB0801609D0 (en) * 2008-01-29 2008-03-05 Binding Site The Ltd Hevylite diagnostic stain

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
WO2005116651A2 (en) * 2004-05-24 2005-12-08 Diasys Corporation Method and device for testing for bence-jones protein
WO2006079816A1 (en) * 2005-01-27 2006-08-03 The Binding Site Limited Method of detecting or monitoring a malignant plasma cell disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Borderline High Serum Free Light Chain κ/λ Ratios Are Seen Not Only in Dialysis Patients but Also in Non–Dialysis-Dependent Renal Impairment and Inflammatory States;George marshall;《Am J Clin Pathol》;20091231;第132卷;第309页 *

Also Published As

Publication number Publication date
JP2013519083A (ja) 2013-05-23
EP2531857A1 (en) 2012-12-12
GB201001950D0 (en) 2010-03-24
JP2013519082A (ja) 2013-05-23
EP2531857B1 (en) 2017-01-18
CN102859362A (zh) 2013-01-02
WO2011095820A1 (en) 2011-08-11
CN102859362B (zh) 2015-11-25
JP5818818B2 (ja) 2015-11-18
US20130217030A1 (en) 2013-08-22
CN102859361A (zh) 2013-01-02
JP5818817B2 (ja) 2015-11-18
US20130149792A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
CN102639999B (zh) 存活预后分析
US8592561B2 (en) Antibodies for detecting or monitoring a malignant plasma cell disease
JP2013521490A (ja) 腎臓予後予測アッセイ
CN102906569A (zh) Flc作为生物标记
CN102859361B (zh) 癌症预后分析
EP2531854B1 (en) Cancer prognosis assay
CN104053994B (zh) 测定
WO2013124630A1 (en) Correction method for estimating free light chain production

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant